Abstract:Epigenetic modifications are involved in the remodeling of the tumor microenvironment (TME) and the regulation of immune response. Nonetheless, the role of histone H4 methylation (H4M) modification in the TME and immune regulation of hepatocellular carcinoma (HCC) is unknown. As a result, the purpose of this research is to discover H4M-mediated modification patterns and their effects on TME and immunologic characteristics in HCC. A total of 2305 samples were enrolled from 13 different cohorts. With the help of consensus clustering analysis, three distinct H4M modification patterns were identified. The cell-infiltrating characteristics of TME under these three patterns were highly consistent with their enriched biological processes and clinical outcome. The H4Mscore was then created using principal component analysis algorithm to quantify the H4M modification pattern of each individual tumor and was systematically correlated with representative tumor characteristics. We found that analyzing H4M modification patterns within individual tumors could predict TME infiltration, homologous recombination deficiency (HRD), intratumor heterogeneity, proliferation activity, mRNA stemness index, and prognosis. The group with a low H4Mscore had an inflamed TME phenotype and a better immunotherapy response, as well as a better survival outcome. The prognostic value of H4Mscore was validated in three internal cohorts and five external cohorts, respectively. In external immunotherapy cohorts, the low H4Mscore was also linked to an enhanced response to anti-PD-1/L1 and anti-CTLA4 immunotherapy and a better prognosis. This study revealed that H4M modification played an important role in forming TME diversity and complexity. Evaluating the H4M modification pattern of individual tumors could help us learn more about TME and develop more effective immunotherapy strategies.

H3K4 trimethylation regulates cancer immunity: a promising therapeutic target in combination with immunotherapy

H3K36 trimethylation-mediated biological functions in cancer

The role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapy

The Roles of H3K9me3 Writers, Readers, and Erasers in Cancer Immunotherapy

Enhancing anti-tumor immune responses through combination therapies: epigenetic drugs and immune checkpoint inhibitors

A New Trend in Cancer Treatment: The Combination of Epigenetics and Immunotherapy

Epigenetic therapy combined with immunotherapy: a novel strategy for cancer therapy

Novel Insights into Histone Lysine Methyltransferases in Cancer Therapy: from Epigenetic Regulation to Selective Drugs

TIM-3, a Promising Target for Cancer Immunotherapy

Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy

H4-methylation Regulators Mediated Epitranscriptome Patterns and Tumor Microenvironment Infiltration Characterization in Hepatocellular Carcinoma

Lysine methylation modifications in tumor immunomodulation and immunotherapy: regulatory mechanisms and perspectives

Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets

The role of histone post-translational modifications in cancer and cancer immunity: functions, mechanisms and therapeutic implications

Recent Advances in Targeting Histone H3 Lysine 36 Methyltransferases for Cancer Therapy

Roles and therapeutic implications of m6A modification in cancer immunotherapy

Chromatin Remodelers Are Regulators of the Tumor Immune Microenvironment

HDAC-targeting epigenetic modulators for cancer immunotherapy

Molecular Mechanisms of Epigenetic Regulators As Activatable Targets in Cancer Theranostics.

Epigenetic Modification-Related Mechanisms of Hepatocellular Carcinoma Resistance to Immune Checkpoint Inhibition

Enhancing the Anticancer Efficacy of Immunotherapy through Combination with Histone Modification Inhibitors